Skip to main content
Premium Trial:

Request an Annual Quote

ReliaGene to Market DNAPrint s Genetic Test to Law Enforcement Agencies

NEW YORK, July 13 (GenomeWeb News) - DNAPrint Genomics said today that DNA testing firm ReliaGene Technologies will distribute its DNAWitness 2.5 genetic testing technology to law enforcement agencies worldwide.

 

DNAPrint said that its technology is well suited to forensic analysis because it can be used to infer physical characteristics based on DNA sequence gleaned from evidence samples. Under the terms of the agreement, New Orleans-based ReliaGene will send forensic samples for certain criminal cases for which there is no suspect to DNAPrint for analysis.

 

ReliaGene, founded in 1990, markets the Y-Plex genotyping system.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.